191 related articles for article (PubMed ID: 34439378)
1. Challenges for Better Diagnosis and Management of Pancreatic and Biliary Tract Cancers Focusing on Blood Biomarkers: A Systematic Review.
Tominaga H; Matsuzaki J; Oikawa C; Toyoshima K; Manabe H; Ozawa E; Shimamura A; Yokoyama R; Serizawa Y; Ochiya T; Saito Y
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439378
[TBL] [Abstract][Full Text] [Related]
2. The Role of Circular RNAs in Pancreatic Ductal Adenocarcinoma and Biliary-Tract Cancers.
Limb C; Liu DSK; Veno MT; Rees E; Krell J; Bagwan IN; Giovannetti E; Pandha H; Strobel O; Rockall TA; Frampton AE
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158116
[TBL] [Abstract][Full Text] [Related]
3. Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare.
Lee JH; Yu SE; Kim KH; Yu MH; Jeong IH; Cho JY; Park SJ; Lee WJ; Han SS; Kim TH; Hong EK; Woo SM; Yoo BC
EPMA J; 2018 Sep; 9(3):287-297. PubMed ID: 30174764
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives.
Arrichiello G; Nacca V; Paragliola F; Giunta EF
Explor Target Antitumor Ther; 2022; 3(3):362-374. PubMed ID: 36045913
[TBL] [Abstract][Full Text] [Related]
5. Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis.
Belkouz A; Labeur TA; Dierks J; Dijk F; van Oijen MGH; Verheij J; van Gulik TM; van de Vijver MJ; Wilmink H; Punt CJA; Klümpen HJ
Crit Rev Oncol Hematol; 2019 Sep; 141():82-94. PubMed ID: 31255992
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs.
Kim K; Yoo D; Lee HS; Lee KJ; Park SB; Kim C; Jo JH; Jung DE; Song SY
BMC Med Genomics; 2019 May; 12(1):62. PubMed ID: 31096984
[TBL] [Abstract][Full Text] [Related]
7. Pathogenetic Role and Clinical Implications of Regulatory RNAs in Biliary Tract Cancer.
Ofoeyeno N; Ekpenyong E; Braconi C
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375055
[TBL] [Abstract][Full Text] [Related]
8. Variants in oxidative stress-related genes affect the chemosensitivity through Nrf2-mediated signaling pathway in biliary tract cancer.
Zhan M; Wang H; Xu SW; Yang LH; Chen W; Zhao SX; Shen H; Liu Q; Yang RM; Wang J
EBioMedicine; 2019 Oct; 48():143-160. PubMed ID: 31590928
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.
Imamura T; Komatsu S; Ichikawa D; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2016 Jul; 22(25):5627-41. PubMed ID: 27433079
[TBL] [Abstract][Full Text] [Related]
10. Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on estimates.
Minicozzi P; Cassetti T; Vener C; Sant M
Cancer Epidemiol; 2018 Aug; 55():52-60. PubMed ID: 29777994
[TBL] [Abstract][Full Text] [Related]
11. Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer.
Marin AM; Sanchuki HBS; Namur GN; Uno M; Zanette DL; Aoki MN
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189687
[TBL] [Abstract][Full Text] [Related]
12. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
[TBL] [Abstract][Full Text] [Related]
13. Novel diagnostic and prognostic biomarkers in biliary tract cancer.
Skipworth JR; Timms JF; Pereira SP
Expert Opin Med Diagn; 2013 Sep; 7(5):487-99. PubMed ID: 23971898
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness and acceleratory effect of macrophage inhibitory cytokine-1 on biliary tract cancer: an experimental biomarker analysis.
Sugimoto M; Suzuki R; Nozawa Y; Takagi T; Konno N; Asama H; Sato Y; Irie H; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Suzuki O; Hashimoto Y; Hikichi T; Ohira H
Cancer Cell Int; 2022 Aug; 22(1):250. PubMed ID: 35948981
[TBL] [Abstract][Full Text] [Related]
15. Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.
Mayr C; Beyreis M; Wagner A; Pichler M; Neureiter D; Kiesslich T
Biomed Res Int; 2016; 2016():4805270. PubMed ID: 27957497
[TBL] [Abstract][Full Text] [Related]
16. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
17. Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers.
Terai K; Jiang M; Tokuyama W; Murano T; Takada N; Fujimura K; Ebinuma H; Kishimoto T; Hiruta N; Schneider WJ; Bujo H
Clin Chim Acta; 2016 Jun; 457():130-6. PubMed ID: 27079357
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of
Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
[TBL] [Abstract][Full Text] [Related]
20. A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer.
Keane MG; Horsfall L; Rait G; Pereira SP
BMJ Open; 2014 Nov; 4(11):e005720. PubMed ID: 25410605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
